Read the First Edition of The Lens, a new magazine by LSI arrow-icon
Learn More About Syndax Pharmaceuticals
Syndax Pharmaceuticals
Reports Graph
Oral histone deacetylase (HDAC) inhibitor that inhibits cancer-relevant HDAC enzymes, which contribute to epigenetic alterations driving cancer growth and drug tolerance
Technology/product details
Revenue projections
Capital raised to date
Growth strategy
Competing Startups
More

Get a Demo and See the Full Profile

Get a demo today to see profiles of Spineology plus 6164 other startups.

Trusted By The Companies Pioneering What’s Next